Charles Schwab Investment Management Inc Ocular Therapeutix, Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,131,485 shares of OCUL stock, worth $8.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,131,485
Previous 1,110,460
1.89%
Holding current value
$8.41 Million
Previous $9.66 Million
0.01%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding OCUL
# of Institutions
183Shares Held
136MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL13.9MShares$103 Million98.85% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$94.8 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$94.5 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$85.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$63 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $572M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...